481 related articles for article (PubMed ID: 28554330)
1. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
Popkirov S; Ayzenberg I; Hahn S; Bauer J; Denno Y; Rieckhoff N; Radzimski C; Hans VH; Berg S; Roghmann F; Noldus J; Bien CG; Skodda S; Wellmer J; Stöcker W; Krogias C; Gold R; Schlegel U; Probst C; Komorowski L; Miske R; Kleiter I
Acta Neuropathol Commun; 2017 May; 5(1):40. PubMed ID: 28554330
[TBL] [Abstract][Full Text] [Related]
2. Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.
Miske R; Scharf M; Borowski K; Rieckhoff N; Teegen B; Denno Y; Probst C; Guthke K; Didrihsone I; Wildemann B; Ruprecht K; Komorowski L; Jarius S
J Neuroinflammation; 2023 Mar; 20(1):88. PubMed ID: 36997937
[TBL] [Abstract][Full Text] [Related]
3. BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis.
Sabater L; Gómez-Choco M; Saiz A; Graus F
J Neuroimmunol; 2005 Dec; 170(1-2):186-90. PubMed ID: 16165222
[TBL] [Abstract][Full Text] [Related]
4. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
6. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
7. Neuronal Na+/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome.
Scharf M; Miske R; Heidenreich F; Giess R; Landwehr P; Blöcker IM; Begemann N; Denno Y; Tiede S; Dähnrich C; Schlumberger W; Unger M; Teegen B; Stöcker W; Probst C; Komorowski L
Neurology; 2015 Apr; 84(16):1673-9. PubMed ID: 25809299
[TBL] [Abstract][Full Text] [Related]
8. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
10. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker.
Dubey D; Kryzer T; Guo Y; Clarkson B; Cheville JC; Costello BA; Leibovich BC; Algeciras-Schimnich A; Lucchinnetti C; Hammami MB; Knight AM; Howe C; Lennon VA; McKeon A; Pittock SJ
Ann Neurol; 2021 May; 89(5):1001-1010. PubMed ID: 33583072
[TBL] [Abstract][Full Text] [Related]
11. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis.
Mundiyanapurath S; Jarius S; Probst C; Stöcker W; Wildemann B; Bösel J
J Neuroimmunol; 2013 Jun; 259(1-2):88-91. PubMed ID: 23628208
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.
Jammoul A; Li Y; Rae-Grant A
Cleve Clin J Med; 2016 Jan; 83(1):43-53. PubMed ID: 26760522
[TBL] [Abstract][Full Text] [Related]
13. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
14. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
15. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles.
Mangioris G; Halfdanarson TR; Lennon VA; Chang BK; Dubey D; Dyck PJB; Flanagan EP; McKeon A; Mills JR; Pittock SJ; Zekeridou A
Eur J Neurol; 2024 Jun; 31(6):e16273. PubMed ID: 38466015
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
17. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery.
Segal Y; Zekeridou A
Curr Opin Neurol; 2024 Jun; 37(3):295-304. PubMed ID: 38533672
[TBL] [Abstract][Full Text] [Related]
18. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.
Vincent A; Bien CG
Lancet Neurol; 2008 Dec; 7(12):1074-5. PubMed ID: 18851929
[No Abstract] [Full Text] [Related]
19. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
